Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China flag China · Delayed Price · Currency is CNY
11.49
+0.04 (0.35%)
Apr 30, 2026, 3:04 PM CST

SHE:301211 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 2021 - 2018
Cash & Equivalents
425.28447.66543.141,6941,8581,860
Upgrade
Trading Asset Securities
1,1151,1071,094129.4103.98-
Upgrade
Cash & Short-Term Investments
1,5401,5551,6371,8241,9621,860
Upgrade
Cash Growth
-5.16%-5.00%-10.26%-7.05%5.50%438.28%
Upgrade
Accounts Receivable
99.5491.4775.5375.08127.47161.05
Upgrade
Other Receivables
4.885.959.262.661.353.09
Upgrade
Receivables
104.4297.4284.7977.74128.82164.14
Upgrade
Inventory
125.84122.68137.85173.8114.789.5
Upgrade
Other Current Assets
21.9916.5715.2823.5921.2115.67
Upgrade
Total Current Assets
1,7921,7921,8752,0992,2272,129
Upgrade
Property, Plant & Equipment
524.38525.89527.75361.99184.8131.7
Upgrade
Long-Term Investments
10.3810.389.64---
Upgrade
Other Intangible Assets
66.366.8368.9471.0773.2766.67
Upgrade
Long-Term Deferred Tax Assets
2.362.362.052.192.391.52
Upgrade
Long-Term Deferred Charges
4.314.381.051.33--
Upgrade
Other Long-Term Assets
0.180.434.6111.0311.471.24
Upgrade
Total Assets
2,4002,4022,4892,5472,4992,330
Upgrade
Accounts Payable
59.472.27116.04117.7182.6236.13
Upgrade
Accrued Expenses
10.3917.0914.9912.9211.648.86
Upgrade
Current Portion of Leases
-1.131.591.510.97-
Upgrade
Current Income Taxes Payable
4.331.133.1314.2718.1412.84
Upgrade
Current Unearned Revenue
15.959.1511.8715.0169.726.34
Upgrade
Other Current Liabilities
13.1213.7816.7613.7325.8238.84
Upgrade
Total Current Liabilities
104.33114.55164.38175.14208.91103.01
Upgrade
Long-Term Leases
1.222.013.625.156.43-
Upgrade
Long-Term Unearned Revenue
1.951.962.042.10.220.28
Upgrade
Long-Term Deferred Tax Liabilities
10.1310.138.927.496.74.24
Upgrade
Total Liabilities
117.63128.65178.97189.89222.26107.53
Upgrade
Common Stock
417.6417.6288288240240
Upgrade
Additional Paid-In Capital
1,6271,6271,7571,7571,8051,805
Upgrade
Retained Earnings
237.61228.39265.48312.17232.06178.26
Upgrade
Comprehensive Income & Other
0.370.33-0.3---
Upgrade
Total Common Equity
2,2822,2732,3102,3572,2772,223
Upgrade
Shareholders' Equity
2,2822,2732,3102,3572,2772,223
Upgrade
Total Liabilities & Equity
2,4002,4022,4892,5472,4992,330
Upgrade
Total Debt
2.353.135.226.667.4-
Upgrade
Net Cash (Debt)
1,5381,5521,6311,8171,9551,860
Upgrade
Net Cash Growth
-5.00%-4.88%-10.22%-7.04%5.10%438.28%
Upgrade
Net Cash Per Share
3.643.563.924.344.715.97
Upgrade
Filing Date Shares Outstanding
460.9417.6417.6417.6417.6417.6
Upgrade
Total Common Shares Outstanding
460.9417.6417.6417.6417.6417.6
Upgrade
Working Capital
1,6881,6771,7101,9242,0182,026
Upgrade
Book Value Per Share
4.955.445.535.645.455.32
Upgrade
Tangible Book Value
2,2162,2062,2412,2862,2032,156
Upgrade
Tangible Book Value Per Share
4.815.285.375.475.285.16
Upgrade
Buildings
-286.89257.27114.69107.54103.36
Upgrade
Machinery
-460.78405.47185.73180.96173.8
Upgrade
Construction In Progress
-8.253.5228.7751.562.17
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.